Connective Tissue Disorders and Fragile X Molecular Status in Females: A Case Series and Review

• Published in: International journal of molecular sciences 2022-08, Vol.23 (16), p.9090
• Main Authors: Butler, Merlin G, Hossain, Waheeda A, Steinle, Jacob, Gao, Harry, Cox, Eleina, Niu, Yuxin, Quach, May, Veatch, Olivia J
• Format: Article
• Language: English
• Subjects: Alleles; Case Report; Chi-square test; Collagen; Connective tissue; Connective Tissue - metabolism; Connective tissue diseases; connective tissue-related disorders; Down's syndrome; Ehlers-Danlos syndrome; Extracellular matrix; Female; Females; Fibromyalgia; FMR1 gene; FMR1 gray zone or intermediate alleles; Fragile X Mental Retardation Protein - genetics; Fragile X Mental Retardation Protein - metabolism; Fragile X syndrome; Fragile X Syndrome - metabolism; Fragility; Genes; Hernias; Humans; Infant, Newborn; Intellectual disabilities; Marfan syndrome; Mitral valve; Mitral valve prolapse; Mutation; Next-generation sequencing; Patients; Proteins; Signs and symptoms; Synaptogenesis; Trinucleotide Repeat Expansion; Trinucleotide Repeats
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23169090

Fragile X syndrome (FXS) is the most common inherited cause of intellectual disabilities and the second most common cause after Down syndrome. FXS is an X-linked disorder due to a full mutation of the CGG triplet repeat of the FMR1 gene which codes for a protein that is crucial in synaptogenesis and maintaining functions of extracellular matrix-related proteins, key for the development of normal neuronal and connective tissue including collagen. In addition to neuropsychiatric and behavioral problems, individuals with FXS show physical features suggestive of a connective tissue disorder including loose skin and joint laxity, flat feet, hernias and mitral valve prolapse. Disturbed collagen leads to hypermobility, hyperextensible skin and tissue fragility with musculoskeletal, cardiovascular, immune and other organ involvement as seen in hereditary disorders of connective tissue including Ehlers−Danlos syndrome. Recently, FMR1 premutation repeat expansion or carrier status has been reported in individuals with connective tissue disorder-related symptoms. We examined a cohort of females with features of a connective tissue disorder presenting for genetic services using next-generation sequencing (NGS) of a connective tissue disorder gene panel consisting of approximately 75 genes. In those females with normal NGS testing for connective tissue disorders, the FMR1 gene was then analyzed using CGG repeat expansion studies. Three of thirty-nine females were found to have gray zone or intermediate alleles at a 1:13 ratio which was significantly higher (p < 0.05) when compared with newborn females representing the general population at a 1:66 ratio. This association of connective tissue involvement in females with intermediate or gray zone alleles reported for the first time will require more studies on how the size variation may impact FMR1 gene function and protein directly or in relationship with other susceptibility genes involved in connective tissue disorders.